Happy Birthday, Omicron
One year after the variant ’s discovery, virologists are still scrambling to keep up with Omicron’s rapid evolution. (Source: NYT Health)
Source: NYT Health - November 26, 2022 Category: Consumer Health News Authors: Carl Zimmer Tags: Coronavirus Omicron Variant Coronavirus (2019-nCoV) Immune System Biology and Biochemistry Evolution (Biology) your-feed-science Source Type: news
Cornelia Schroeder obituary
My mother, Cornelia Schroeder, who has died aged 73, was a virologist specialising in influenza and also the editor of her mother ’s memoir.Cornelia spent the early years of her career in her native East Germany, but after its collapse, she went to work at the National Institute for Medical Research in Mill Hill, London. From 1990 to 1993, she was Wellcome research fellow at the institute ’s division of virology, working on isolation of the influenza virus protein. There, she met an international crowd of like-minded people with whom she remained friends and went hiking in west Wales every year - long after she went ba...
Source: Guardian Unlimited Science - November 20, 2022 Category: Science Authors: Paul Schroeder Tags: Medical research Source Type: news
Effects of Low-Frequency Pre-Treatment HIV Drug Resistance Effects of Low-Frequency Pre-Treatment HIV Drug Resistance
A new study suggests that individuals with low-frequency drug-resistant HIV variants may be at a higher risk for experiencing virologic failure after efavirenz-based ART.AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 18, 2022 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
COVID-19: Epidemiology, virology, and prevention, UpToDate (Updated 10th November 2022)
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It rapidly spread, resulting in an epidemic throughout China, followed by a global pandemic. In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019 [ 2 External 0 0 0 1 false https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention/abstract/1 true false%>]. The virus that causes COVID-19 is designated severe acute respiratory syndr...
Source: Current Awareness Service for Health (CASH) - November 15, 2022 Category: Consumer Health News Source Type: news
Ebola could have leaked from US biofacility causing 2014 West Africa outbreak, scientists claim
EXCLUSIVE: Virologist Dr Jonathan Latham - a former researcher at the University of Wisconsin - and journalist Sam Husseini say there are a number of inconsistencies in the official timeline. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2022 Category: Consumer Health News Source Type: news
Opinion
KAMPALA, Uganda — The first major Ebola outbreak in Uganda happened when I was a medical student at Makerere University in Kampala. A professor of virology explained to us the dangers of... #border #virusfamily #professor #uganda #makerereuniversity #ebolaoutbreak #militaryofficer #kampala (Source: Reuters: Health)
Source: Reuters: Health - November 3, 2022 Category: Consumer Health News Source Type: news
Biosecurity Incident in Wuhan; Subpar RSV Surveillance; Inside Healthcare PE Firm
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Biosecurity Incident in Wuhan
In November 2019, reports from the Wuhan Institute of Virology... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 2, 2022 Category: American Health Source Type: news
Covid-19: XBB unlikely to cause severe illness in India, say experts
"It's a sub-variant of Omicron that gets around pre-existing immunity rather well," said Virologist Shahid Jameel of the University of Oxford. (Source: The Economic Times)
Source: The Economic Times - November 1, 2022 Category: Consumer Health News Source Type: news
A New Lab-Made COVID-19 Virus Puts Gain-of-Function Research Under the Microscope
On October 14, a team of scientists at Boston University released a pre-print study reporting that they had created a version of SARS-CoV-2 combining two features of different, existing strains that boosted its virulence and transmissibility. Scientists and the public raised questions about the work, which refocused attention on such experiments, and prompted the U.S. government to investigate whether the research followed protocols for these kinds of studies.
The concerns surround what is known as gain-of-function studies, in which viruses, bacteria, or other pathogens are created in the lab—either intentionally or ...
Source: TIME: Science - October 27, 2022 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
To thwart the next pandemic, ‘swientists’ hunt for flu viruses at U.S. hog shows
.news-article__hero--featured .parallax__element { object-position: 10% 60%; -o-object-position: 10% 60%; } @media (max-width: 991.98px) { .news-article__hero--featured .parallax:before { background: linear-gradient(180deg, rgba(0, 0, 0, 90%), transparent 50%, transparent 85%, rgba(0, 0, 0, 60%) 100%); } .news-article__hero--featured .news-article__hero__info-wrapper { height: 100%; } .news-article__hero--featured .news-article__hero__scroller { bottom: 0; position: absolute; left: calc(50% - 50px); } .parallax__element {} } @media (min-width: 992px) { .news-article__hero--featured ....
Source: ScienceNOW - October 27, 2022 Category: Science Source Type: news
Monkeypox cases are plummeting. Scientists are debating why
When monkeypox cases in Europe began to decline this summer, researchers’ first question was: Is it real? Some worried that people might not be getting tested because of receding fears of the virus, coupled with strict isolation requirements for patients. “They might be reluctant to be confirmed and be told not to go out at all,” says Catherine Smallwood, monkeypox incident manager at the World Health Organization’s (WHO’s) Regional Office for Europe.
But the decline is now unmistakable. WHO Europe, which reported more than 2000 cases per week during the peak in July, is now counting about 100 cases weekly....
Source: ScienceNOW - October 26, 2022 Category: Science Source Type: news
Merck locates frozen batch of undisclosed Ebola vaccine, will donate for testing in Uganda ’s outbreak
In a revelation that may help Uganda combat its outbreak of Ebola, the pharmaceutical giant Merck has acknowledged to
Science—
after repeated inquiries
—
that it has up to 100,000 doses of an experimental vaccine for the deadly viral disease in its freezers in Pennsylvania and will donate them. The World Health Organization (WHO) and the Ugandan government are discussing if and how these doses can be incorporated into one or more clinical trials of
other
candidate Ebola vaccines that could launch as soon as next month.
The Merck vaccine targets Sudan ebolavirus, the pathogen currentl...
Source: ScienceNOW - October 23, 2022 Category: Science Source Type: news
U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 3...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Group salesup 2%[1] at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales in the Pharmaceuticals Divisionat the previous year ’s level with significantly lower sales of COVID-19-related products (Ronapreve and Actemra/RoActemra) and losses to biosimilars, offset by strong growth of newer medicinesSales in the Diagnostics Divisionrise 6%; base business remains strong; as expected, demand for COVID-19 tests sharply down in third quarterHighlights in the third quarter:EU approval forVabysmo (severe eye diseases)US approval...
Source: Roche Investor Update - October 18, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Basel, 18 October 2022Group salesup 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales in the Pharmaceuticals Divisionat the previous year ’s level with significantly lower sales of COVID-19-related products (Ronapreve and Actemra/RoActemra) and losses to biosimilars, offset by strong growth of newer medicinesSales in the Diagnostics Divisionrise 6%; base business remains strong; as expected, demand for COVID-19 tests sharply down in third quarterHighlights in the third quarter:EU approval forVabysmo (severe eye ...
Source: Roche Media News - October 18, 2022 Category: Pharmaceuticals Source Type: news
